Schroder Investment Management Group
ORKA

Schroder Investment Management Group’s Oruka Therapeutics ORKA Stock Holding History

Schroder Investment Management Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Sell
21,453
-7,731
-26% -$515K ﹤0.01% 930
2026
Q1 		$1.33M Hold
29,184
– – ﹤0.01% 997
2025
Q4 		$850K Hold
29,184
– – ﹤0.01% 1009
2025
Q3 		$563K Buy
+29,184
New +$433K ﹤0.01% 1078

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Schroder Investment Management Group's ORKA Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Oruka Therapeutics (ORKA) stake by 26% in Q2 2026, selling an estimated $515K and leaving 21,453 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Schroder Investment Management Group first reported a position in ORKA in Q3 2025 and has held it in 4 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Schroder Investment Management Group held 21,453 shares of Oruka Therapeutics worth $1.98M as of Q2 2026.
  • Schroder Investment Management Group sold 7,731 Oruka Therapeutics shares in Q2 2026, an estimated $515K.
  • Oruka Therapeutics made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #930 holding.
  • Schroder Investment Management Group first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.